Halozyme Therapeutics Inc HALO Q1 2026 Earnings EPS Surpasses Estimates Despite Flat Revenue Disclosure ABXL Q1 2026 Earnings Modest EPS Miss Amid Stable Operations ANIX Q1 2026 Earnings Narrowed Loss Beats Expectations as Pipeline Advances ABR Q1 2026 Earnings EPS Misses Estimates Amid Challenging Real Estate Market BK Q1 2026 Earnings EPS Surges 1326 Above Estimates Shares Steady RenovoRx Q1 2026 Earnings WiderthanExpected Loss as ClinicalStage Biotech Advances Pipeline